Vaxcyte, Inc. (PCVX)
58.13
-2.24
(-3.71%)
USD |
NASDAQ |
Sep 18, 16:00
58.14
0.00 (0.00%)
After-Hours: 20:00
Vaxcyte Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Moderna, Inc. | -7.59% |
| Arrowhead Pharmaceuticals, Inc. | 91.15% |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | 39.18% |
| Sarepta Therapeutics, Inc. | 60.18% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -36.94% |
| Return on Assets | -33.24% |
| Return on Invested Capital | -35.66% |
| Return on Net Operating Assets | -277.4% |